Yep, the other posters are correct. Charlotte has two very large health systems and, so far, a much lower number of severe cases than other major cities/markets. It makes more sense for them to treat more patients quicker by signing on for the mild to moderate. That benefits Cytodyn too, because while there aren’t thousands of severe patients there are more than enough mild to moderate. I also like it as a marker because we haven’t peaked here yet so to know Leronlimab is already in the hospitals should things escalate makes me feel good about its chances to help there too.